Global Custom Market Research Reports Provider Company

phone

Thyroid Function Tests - Medical Devices Pipeline Assessment, 2017

  • Published Date: 01 Aug 2017
  • Number of Pages: 135
  • Category: Healthcare and Medical
  • Country: Global
Thyroid Function Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Thyroid Function Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Thyroid Function Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thyroid Function Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Thyroid Function Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Thyroid Function Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Thyroid Function Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Thyroid Function Tests Overview 7
3 Products under Development 8
3.1 Thyroid Function Tests - Pipeline Products by Stage of Development 8
3.2 Thyroid Function Tests - Pipeline Products by Segment 9
3.3 Thyroid Function Tests - Pipeline Products by Territory 10
3.4 Thyroid Function Tests - Pipeline Products by Regulatory Path 11
3.5 Thyroid Function Tests - Pipeline Products by Estimated Approval Date 12
4 Thyroid Function Tests - Pipeline Products under Development by Companies 13
4.1 Thyroid Function Tests Companies - Pipeline Products by Stage of Development 13
4.2 Thyroid Function Tests - Pipeline Products by Stage of Development 14
5 Thyroid Function Tests Companies and Product Overview 15
5.1 Abbott Diagnostics Company Overview 15
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Achira Labs Pvt Ltd Company Overview 16
5.2.1 Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 AXO Science SAS Company Overview 17
5.3.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 GeneFluidics Inc Company Overview 18
5.4.1 GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Immunodiagnostic Systems Holdings plc Company Overview 21
5.5.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 MedMira Inc. Company Overview 22
5.6.1 MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.7 Mindray Medical International Ltd Company Overview 23
5.7.1 Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.8 Novartis AG Company Overview 25
5.8.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Ohmx Corp Company Overview 26
5.9.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Ortho-Clinical Diagnostics Inc Company Overview 27
5.10.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Protagen AG Company Overview 28
5.11.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 28
5.12 Quidel Corp Company Overview 29
5.12.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.13 Siemens Healthcare GmbH Company Overview 31
5.13.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 31
5.14 Sysmex Corp Company Overview 37
5.14.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 37
5.15 Toshiba Medical Systems Corporation Company Overview 40
5.15.1 Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 True Diagnostics Inc Company Overview 41
5.16.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 University Rovira i Virgili Company Overview 43
5.17.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 43
6 Thyroid Function Tests- Recent Developments 44
6.1 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 44
6.2 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review 45
6.3 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 48
6.4 Jul 18, 2017: Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products 50
6.5 Jul 06, 2017: Kurt H. Kruger joins Qualigens Board of Directors 56
6.6 Jul 06, 2017: Richard David, MD, FACS joins Qualigens Board of Directors 56
6.7 Jun 29, 2017: MedMira Reports FY2017 Third Quarter Results 57
6.8 Jun 21, 2017: Immunodiagnostic Systems Holdings: Final Results for year ended 31 March 2017 57
6.9 Jun 07, 2017: Quidel Receives the CE Mark for Its Thyretain TBI Reporter BioAssay 58
6.10 May 16, 2017: NOWDiagnostics CEO Kevin Clark to Address Technology Conference 58
6.11 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy 59
6.12 May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 60
6.13 May 03, 2017: Veracyte Announces First Quarter 2017 Financial Results 61
6.14 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 62
6.15 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued 63
6.16 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 68
6.17 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 70
6.18 Apr 17, 2017: Toshiba Medical Names Dan Skyba Director of Ultrasound Business Unit 73
6.19 Mar 31, 2017: MedMira Reports FY2017 Second Quarter Results 73
6.20 Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 73
6.21 Mar 13, 2017: Immunodiagnostic Systems Holdings Re-Appoints CEO 75
6.22 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 75
6.23 Mar 01, 2017: Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook 76
6.24 Feb 28, 2017: Veracyte Announces Executive Promotions 77
6.25 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting 77
6.26 Feb 24, 2017: Immunodiagnostic Systems Holdings: Update on CEO Appointment 78
6.27 Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 78
6.28 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 80
6.29 Jan 30, 2017: MedMira Announces AGM Results and Stock Option Grant 82
6.30 Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 83
6.31 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report 83
6.32 Jan 26, 2017: Achievement of sales milestone for COPD products 84
6.33 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback 84
6.34 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 92
6.35 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 92
6.36 Jan 19, 2017: Immunodiagnostic Systems Holdings Announces Directorate Change 94
6.37 Dec 30, 2016: MedMira Reports 2017 First Quarter Financial Results 95
6.38 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 95
6.39 Dec 13, 2016: Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors 96
6.40 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda 97
6.41 Nov 28, 2016: MedMira Reports 2016 Fourth Quarter and Year End Financial Results 98
6.42 Nov 25, 2016: Immunodiagnostic Systems Holdings: Interim Results for the six month period ended 30 September 2016 98
6.43 Nov 21, 2016: Veracyte appoints new CFO 99
6.44 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016 99
6.45 Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 100
6.46 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 101
6.47 Nov 03, 2016: Veracyte Announces Third Quarter 2016 Financial Results 102
6.48 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 103
6.49 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters 104
6.50 Oct 21, 2016: Immunodiagnostic Systems Holdings: H1 Trading Update 111
6.51 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 112
6.52 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 115
6.53 Oct 17, 2016: Veracyte Releases Preliminary Third Quarter 2016 Financial Results 118
6.54 Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors 118
6.55 Sep 26, 2016: PerkinElmer Announces New Organizational Structure 119
6.56 Aug 31, 2016: bioMerieux - First-Half 2016 Results 119
6.57 Aug 09, 2016: Ortho Clinical Diagnostics Featured in Clinical Lab Products 123
6.58 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 124
6.59 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 125
6.60 Aug 03, 2016: Veracyte Announces Second Quarter 2016 Financial Results 129
6.61 Aug 01, 2016: Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016 130
6.62 Aug 01, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease 131
7 Appendix 132
7.1 Methodology 132
7.2 About GlobalData 135
7.3 Contact Us 135
7.4 Disclaimer 135

List Of Tables


Table 1: Thyroid Function Tests - Pipeline Products by Stage of Development 8
Table 2: Thyroid Function Tests - Pipeline Products by Segment 9
Table 3: Thyroid Function Tests - Pipeline Products by Territory 10
Table 4: Thyroid Function Tests - Pipeline Products by Regulatory Path 11
Table 5: Thyroid Function Tests - Pipeline Products by Estimated Approval Date 12
Table 6: Thyroid Function Tests Companies - Pipeline Products by Stage of Development 13
Table 7: Thyroid Function Tests - Pipeline Products by Stage of Development 14
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Alinity ci - Thyroid Disease - Product Status 15
Table 10: Alinity ci - Thyroid Disease - Product Description 15
Table 11: Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: TSH Diagnostic Panel - Product Status 16
Table 13: TSH Diagnostic Panel - Product Description 16
Table 14: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 17
Table 15: Multiplexed Detection - TSH - Product Status 17
Table 16: Multiplexed Detection - TSH - Product Description 17
Table 17: GeneFluidics Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 18: Free T3 Assay - Product Status 18
Table 19: Free T3 Assay - Product Description 18
Table 20: Free T4 Assay - Product Status 19
Table 21: Free T4 Assay - Product Description 19
Table 22: T3 Assay - Product Status 19
Table 23: T3 Assay - Product Description 20
Table 24: T4 Assay - Product Status 20
Table 25: T4 Assay - Product Description 20
Table 26: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 27: IDS-iSYS Bioactive PTH (1-84) Kit - Product Status 21
Table 28: IDS-iSYS Bioactive PTH (1-84) Kit - Product Description 21
Table 29: MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 30: Reveal TSH Single Test - Product Status 22
Table 31: Reveal TSH Single Test - Product Description 22
Table 32: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
Table 33: CL-2000i - Anti-TG Test - Product Status 23
Table 34: CL-2000i - Anti-TG Test - Product Description 23
Table 35: CL-2000i - Anti-TPO - Product Status 24
Table 36: CL-2000i - Anti-TPO - Product Description 24
Table 37: CL-2000i - Thyroglobulin (TG) Test - Product Status 24
Table 38: CL-2000i - Thyroglobulin (TG) Test - Product Description 24
Table 39: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 25
Table 40: Diagnostic Test - Thyroid Stimulating Hormone - Product Status 25
Table 41: Diagnostic Test - Thyroid Stimulating Hormone - Product Description 25
Table 42: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview 26
Table 43: Portable POC System - Thyroid Stimulating Hormone - Product Status 26
Table 44: Portable POC System - Thyroid Stimulating Hormone - Product Description 26
Table 45: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 46: Diagnostic Assay - Thyroid Diseases - Product Status 27
Table 47: Diagnostic Assay - Thyroid Diseases - Product Description 27
Table 48: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 28
Table 49: Diagnostic Assay - Thyroid Disease - Product Status 28
Table 50: Diagnostic Assay - Thyroid Disease - Product Description 28
Table 51: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 52: Sofia - Thyroid Stimulating Hormone - Product Status 29
Table 53: Sofia - Thyroid Stimulating Hormone - Product Description 29
Table 54: Thyretain TBI Reporter BioAssay - Product Status 30
Table 55: Thyretain TBI Reporter BioAssay - Product Description 30
Table 56: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 31
Table 57: ADVIA Centaur CP Immunoassay System - Tg Assay - Product Status 31
Table 58: ADVIA Centaur CP Immunoassay System - Tg Assay - Product Description 32
Table 59: ADVIA Centaur XP Immunoassay System - Tg Assay - Product Status 32
Table 60: ADVIA Centaur XP Immunoassay System - Tg Assay - Product Description 32
Table 61: ADVIA Centaur XPT Immunoassay System - Tg Assay - Product Status 33
Table 62: ADVIA Centaur XPT Immunoassay System - Tg Assay - Product Description 33
Table 63: Dimension Vista 1000T Intelligent Lab System - Intact PTH Assay - Product Status 33
Table 64: Dimension Vista 1000T Intelligent Lab System - Intact PTH Assay - Product Description 34
Table 65: Dimension Vista 1500 Intelligent Lab System - Intact PTH Assay - Product Status 34
Table 66: Dimension Vista 1500 Intelligent Lab System - Intact PTH Assay - Product Description 34
Table 67: Dimension Vista 3000T Intelligent Lab System - Intact PTH Assay - Product Status 35
Table 68: Dimension Vista 3000T Intelligent Lab System - Intact PTH Assay - Product Description 35
Table 69: Dimension Vista 500 Intelligent Lab System - Intact PTH Assay - Product Status 35
Table 70: Dimension Vista 500 Intelligent Lab System - Intact PTH Assay - Product Description 35
Table 71: IMMULITE 1000 Immunoassay System - TSI Assay - Product Status 36
Table 72: IMMULITE 1000 Immunoassay System - TSI Assay - Product Description 36
Table 73: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 37
Table 74: Immunochemistry Test - Tg Ab - Product Status 37
Table 75: Immunochemistry Test - Tg Ab - Product Description 37
Table 76: Immunochemistry Test - TPO Ab - Product Status 38
Table 77: Immunochemistry Test - TPO Ab - Product Description 38
Table 78: Immunochemistry Test - TR Ab - Product Status 38
Table 79: Immunochemistry Test - TR Ab - Product Description 39
Table 80: Toshiba Medical Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
Table 81: Diagnostic Test - Thyroid Disorders - Product Status 40
Table 82: Diagnostic Test - Thyroid Disorders - Product Description 40
Table 83: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 84: TrueDX - Thyroid Health - Product Status 41
Table 85: TrueDX - Thyroid Health - Product Description 41
Table 86: TrueDX - TSH Test - Product Status 42
Table 87: TrueDX - TSH Test - Product Description 42
Table 88: University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview 43
Table 89: CD-Medics Test - Thyroiditis - Product Status 43
Table 90: CD-Medics Test - Thyroiditis - Product Description 43
Table 91: Glossary 134

List Of Figures


Figure 1: Thyroid Function Tests - Pipeline Products by Stage of Development 8
Figure 2: Thyroid Function Tests - Pipeline Products by Segment 9
Figure 3: Thyroid Function Tests - Pipeline Products by Territory 10
Figure 4: Thyroid Function Tests - Pipeline Products by Regulatory Path 11
Figure 5: Thyroid Function Tests - Pipeline Products by Estimated Approval Date 12

This report studies Thyroid Hormone Disorder Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these

View Report

Hypothyroidism Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Hypothyroidism Global Clinical Trials Review, H2, 2017 provides an overview of Hypothyroidism clinical trials scenario. This report provides top line

View Report

Hypoparathyroidism Global Clinical Trials Review, H2, 2017 GlobalDatas clinical trial report, Hypoparathyroidism Global Clinical Trials Review, H2, 2017 provides an overview of Hypoparathyroidism clinical trials scenario. This report provides top line

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports